Alemtuzumab and myelodysplastic syndrome Patient Reports February 13, 2012
Alemtuzumab Side Effects Report #5669134-8
Alemtuzumab side effect was reported by a Physician from UNITED STATES on Feb 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Alemtuzumab dosage: unknown. Patient recovered.
Alemtuzumab Side Effects Report #5670250-5
Alemtuzumab side effect was reported by a Physician from UNITED STATES on Feb 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Alemtuzumab dosage: unknown. Patient recovered.
Alemtuzumab Side Effects Report #6005838-5
Alemtuzumab side effect was reported by a Physician from UNITED STATES on Dec 02, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Alemtuzumab dosage: unknown. Patient recovered.
Alemtuzumab Side Effects Report #6020496-1
Alemtuzumab side effect was reported by a Physician from UNITED STATES on Dec 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Alemtuzumab dosage: unknown. Patient recovered.
Alemtuzumab and myelodysplastic syndrome 